Rethinking Rogers' Bell Curve: Innovation Diffusion, Its Evolution, and the AI Glacier in Healthcare

Everett Rogers noted that even clearly superior ideas often struggle to be adopted, a phenomenon that has fascinated scholars of innovation diffusion since his seminal 1983 work, Diffusion of Innovations . He defined diffusion as the process by which an innovation spreads through specific channels over time within a social system.

Rogers emphasized that innovation inherently carries uncertainty—uncertainty about alternatives, their effectiveness, and the comparison with the status quo. Modern technological innovations amplify this uncertainty, as users must assess a new tool’s efficacy relative to existing solutions.

Rogers' classic bell‑curve model depicts adopter categories as a normal distribution: innovators (2.5%), early adopters (13.5%), early majority (34.5%), late majority (34.5%), and laggards (16%). Adoption proceeds through four cognitive stages—awareness, decision, initial use, and continued use—driven by five perceived attributes: relative advantage, compatibility, complexity, trialability, and observability.

Although the model has succeeded across many domains, it shows limitations in healthcare, where it neglects stakeholder diversity (patients, providers, payers, etc.), focuses on adoption rather than discontinuation, and overlooks organizational resources and peer support.

Evolution of Rogers' Bell Curve

Since the 1960s the bell‑curve has been extended. The first major evolution is the technology S‑curve introduced by Richard Foster (1986) and popularized by Clayton Christensen (1997) in The Innovator's Dilemma . The S‑curve links cost or time on the x‑axis with performance on the y‑axis, highlighting the need for timely market entry and continuous innovation.

Geoffrey Moore (1991) added the "crossing the chasm" concept, arguing that early adopters differ psychologically from the early majority, creating a gap that requires extensive education, marketing, and capital—often referred to as the "valley of death" for startups.

From 1998 to 2008 Carl May and colleagues developed Normalization Process Theory (NPT) to explain how new practices become embedded in healthcare organizations through implementation, embedding, and integration processes.

Artificial Intelligence Glacier in Healthcare

AI promises to transform healthcare from reactive to predictive care, yet adoption remains sluggish. Five key reasons are identified: (1) many AI startups apply consumer‑tech models that ignore healthcare’s regulatory, risk‑averse, and stakeholder‑complex environment; (2) the valley of death is deepened by longer adoption cycles and talent scarcity; (3) AI often lacks relative advantage, compatibility, and trialability in clinical settings; (4) innovators and early adopters are socially distinct from the broader user base, hindering communication; (5) clinical validation of AI is costly and rare, leading to insufficient evidence and heightened skepticism.

Addressing these challenges may require redefining disruption, as Christensen suggests: disruption starts at the market fringe, evolves over time, and eventually replaces incumbent technologies after decades. Startups that continuously innovate can survive the valley of death by leveraging early‑customer feedback and low‑cost iterative development.

In summary, the diffusion of AI in healthcare is constrained by a combination of theoretical, organizational, and market factors that together form a deep "glacier" of adoption challenges.